Genprex Statistics
Total Valuation
Genprex has a market cap or net worth of $1.70 million. The enterprise value is -$13.46 million.
| Market Cap | 1.70M |
| Enterprise Value | -13.46M |
Important Dates
The next estimated earnings date is Friday, November 20, 2026, after market close.
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genprex has 819,709 shares outstanding. The number of shares has increased by 1,725.61% in one year.
| Current Share Class | 819,709 |
| Shares Outstanding | 819,709 |
| Shares Change (YoY) | +1,725.61% |
| Shares Change (QoQ) | +49.73% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 1.54% |
| Float | 818,721 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.07 |
| P/TBV Ratio | 0.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.77, with zero debt.
| Current Ratio | 6.77 |
| Quick Ratio | 6.47 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.41 |
Financial Efficiency
Return on equity (ROE) is -203.86% and return on invested capital (ROIC) is -122.35%.
| Return on Equity (ROE) | -203.86% |
| Return on Assets (ROA) | -94.46% |
| Return on Invested Capital (ROIC) | -122.35% |
| Return on Capital Employed (ROCE) | -107.08% |
| Weighted Average Cost of Capital (WACC) | -1.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.27M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.39% in the last 52 weeks. The beta is -0.99, so Genprex's price volatility has been lower than the market average.
| Beta (5Y) | -0.99 |
| 52-Week Price Change | -98.39% |
| 50-Day Moving Average | 2.80 |
| 200-Day Moving Average | 18.85 |
| Relative Strength Index (RSI) | 37.48 |
| Average Volume (20 Days) | 192,260 |
Short Selling Information
The latest short interest is 124,916, so 15.24% of the outstanding shares have been sold short.
| Short Interest | 124,916 |
| Short Previous Month | 97,072 |
| Short % of Shares Out | 15.24% |
| Short % of Float | 15.26% |
| Short Ratio (days to cover) | 0.45 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.84M |
| Pretax Income | -16.50M |
| Net Income | -16.50M |
| EBITDA | n/a |
| EBIT | -15.84M |
| Earnings Per Share (EPS) | -$71.69 |
Balance Sheet
The company has $15.15 million in cash and no debt, with a net cash position of $15.15 million or $18.49 per share.
| Cash & Cash Equivalents | 15.15M |
| Total Debt | n/a |
| Net Cash | 15.15M |
| Net Cash Per Share | $18.49 |
| Equity (Book Value) | 14.80M |
| Book Value Per Share | 29.23 |
| Working Capital | 13.50M |
Cash Flow
| Operating Cash Flow | -15.56M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -15.56M |
| FCF Per Share | -$18.99 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Genprex does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1,725.61% |
| Shareholder Yield | -1,725.61% |
| Earnings Yield | -3,463.31% |
| FCF Yield | -917.18% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on July 16, 2026. It was a reverse split with a ratio of 1:22.
| Last Split Date | Jul 16, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:22 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |